Medical Condition News

RSS

Combination therapy improves survival in patients with hepatocellular carcinoma

Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.

22 Nov 2019

Accelerating Medicines Partnership program for Parkinson’s disease launches new data portal

The Accelerating Medicines Partnership program for Parkinson's disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to researchers working to develop effective therapies for the disease.

22 Nov 2019

New targeted treatment for insomnia has fewer side effects

Insomnia is one of the most common sleep disorders, and is most commonly treated with hypnotics. However, hypnotics have motor and cognitive side effects.

22 Nov 2019

Predicting opioid-related problems among cancer survivors

Opioids play an important role in how cancer patients manage pain, but the ongoing opioid epidemic has raised concerns about their potential for abuse.

22 Nov 2019

Insufficient sleep may explain why disadvantaged groups have more heart disease

Insufficient sleep is one reason why disadvantaged groups have more heart disease. That's the finding of a study published today in Cardiovascular Research, a journal of the European Society of Cardiology.

22 Nov 2019

Study finds increase in peritoneal dialysis use in the U.S. after Medicare payment reform

More US patients with kidney failure started, stayed on, and switched to peritoneal dialysis following a payment policy implemented in 2011 by Medicare.

22 Nov 2019

Study underscores the influence of sensory processing in multiple sclerosis

A team of researchers published new findings about the role of sensory processing and disease characteristics in the functional status of individuals with multiple sclerosis.

22 Nov 2019

Researchers discover molecular underpinnings of Alexander disease

Scientists have known that genetic mutations leading to the production of a defective protein called GFAP cause Alexander disease (AxD), a debilitating neurodegenerative condition that can present during infancy, adolescence, or adulthood.

21 Nov 2019

Cancer patients more likely to die from stroke than general public

People living with or beyond cancer are more likely to die from stroke than the general public, according to new Penn State research, and certain types of cancer may boost the risk even more.

21 Nov 2019

UM trial to evaluate new stent as a treatment option for aneurysms

Robert M. Starke, M.D., M.Sc., an experienced neurosurgeon and researcher with the University of Miami Health System and Miller School of Medicine, has been conducting laboratory studies on a specialized stent designed to treat complex aneurysms in the blood vessels of the brain.

21 Nov 2019

Researchers uncover critical role of PKM2 protein in multiple inflammatory diseases

A research team in Trinity College Dublin has uncovered a critical role for a protein called 'PKM2' in the regulation of immune cell types at the heart of multiple inflammatory diseases.

21 Nov 2019

Frailty: An important predictor of worse outcome after traumatic spinal cord injury

A new study has shown that frailty is an important predictor of worse outcome after traumatic spinal cord injury in patients less than 75 years of age. In patients younger than 75 years, frailty was a predictor of adverse events, acute length of stay, and in-hospital mortality, as reported in an article published in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

21 Nov 2019

CU Anschutz to train students to prescribe buprenorphine products for opioid use disorder

As the nation struggles with a persistent epidemic of opioid addiction, the University of Colorado Anschutz Medical Campus is taking a critical step that will allow its graduates to better treat patients and save lives.

21 Nov 2019

UTSA research aims to use sulfur to expedite new drug development

Organosulfur compounds are widely present in our bodies and the natural environment. They are found in onions, shallots and even cauliflower. Medical research finds that when consumed, they can protect against cancer, heart disease and even diabetes. There is also evidence of these compounds' antiviral and antibacterial uses. About a quarter of all pharmaceutical drugs currently use OSCs.

21 Nov 2019

Researchers design new antitumoral drug release strategy for breast cancer treatment

The local release of antitumoral drugs through bacterial proteins in the treatment of breast cancer can mark a before and after in precision medicine.

21 Nov 2019

Chinese scientists suggest alternative strategy for combating obesity

Overweight and obesity have become a severe public health problem around the world. Current anti-obesity strategies are mainly aimed at restricting calorie intake and absorption. Now, Chinese scientists suggest in a new study that burning energy by activation of brown adipose tissue (BAT) might be an alternative strategy for combating obesity.

21 Nov 2019

New study tracks musical rhythm as potential treatment for autism

Researchers from the Vanderbilt Bill Wilkerson Center and the Marcus Autism Center at Emory University School of Medicine are partnering to study musical rhythm synchronization as a part of social development and how it's disrupted in children with autism spectrum disorder in hopes of developing music interventions for improving social communication.

21 Nov 2019

Study could help predict resistance to pancreatic cancer treatments

A study from the University of North Carolina Lineberger Comprehensive Cancer Center could help predict resistance to treatments for pancreatic cancer, one of the deadliest cancer types.

21 Nov 2019

Anti-epileptic drugs linked to increase in patients' risk of suicide

Three of the most common forms of anti-epileptic drugs in Denmark is associated with increase in patients' risk of suicide. However, the risk is low and should be seen in conjunction with the many beneficial effects of the medicines.

21 Nov 2019

Kessler Foundation to study use of minimally invasive treatment for meniscal tears

Kessler Foundation received a $590,000 award from The Geneva Foundation for a three-year study of the use of a an experimental minimally invasive treatment for meniscal tears--the injection of autologous micro-fragmented adipose tissue into the knee joint.

21 Nov 2019